SEC 13F Intelligence

Octagon Capital Advisors LP / AVBP

Octagon Capital Advisors LP’s Arrivent Biopharma Inc Position

Does Octagon Capital Advisors LP own Arrivent Biopharma Inc (AVBP)? Yes — 1.97M shares worth $45M (+5.03% of its 13F portfolio) as of Q1 2026.

Position Value
$45M
Q1 2026
Shares
1.97M
% of Portfolio
+5.03%
Quarters Held
9
currently held

Position History AVBP

Reported value by quarter
Q1 ’24: $35MQ1 ’24Q2 ’24: $33MQ3 ’24: $46MQ3 ’24Q4 ’24: $55MQ1 ’25: $38MQ1 ’25Q2 ’25: $42MQ3 ’25: $36MQ3 ’25Q4 ’25: $40MQ1 ’26: $45MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.97M$45M+5.03%
Q4 20251.97M$40M+4.81%
Q3 20251.97M$36M+5.51%
Q2 20251.95M$42M+9.30%
Q1 20252.06M$38M+7.37%
Q4 20242.06M$55M+9.03%
Q3 20241.98M$46M+7.22%
Q2 20241.80M$33M+5.26%
Q1 20241.94M$35M+4.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of AVBP.